Quetiapine is a type of medicine used to treat mental health conditions like schizophrenia and bipolar disorder. It works by affecting chemicals in the brain, specifically targeting certain receptors to help manage symptoms. It's often prescribed by doctors to help people feel better.
Every report comes from a Lived member, sent anonymously.
Have you tried Seroquel (Quetiapine) for Bipolar Disorder?
Quetiapine, sold as Seroquel and Seroquel XR and widely available as a generic, is an atypical (second-generation) antipsychotic. It is approved to treat schizophrenia, a condition that affects how a person thinks, perceives and behaves, and bipolar disorder, in which periods of depression alternate with periods of mania (an unusually elevated or irritable mood with high energy and less need for sleep). In bipolar disorder it has several distinct roles: treating an episode of mania, alone or alongside the mood stabilizers lithium or divalproex; treating an episode of bipolar depression on its own; and, together with lithium or divalproex, helping prevent new episodes over the long term. It is also approved for schizophrenia in teenagers 13 and older and for bipolar mania in children 10 and older, as part of a broader treatment program. The extended-release form, Seroquel XR, has one additional approval: as an add-on for adults with major depressive disorder whose symptoms have not improved enough on an antidepressant alone. The immediate-release form is not approved for that use. Because quetiapine is sedating, low doses are often prescribed off-label for sleep. Evidence-based guidelines recommend against this, because a benefit for insomnia has not been shown and the safety concerns are real. In one observational study of adults 65 and older, low-dose quetiapine for sleep was linked with more deaths, falls and new dementia diagnoses than trazodone, another medicine prescribed for sleep.
Exactly how quetiapine relieves psychosis, mania and depression is not fully understood. Its main effect is thought to come from blocking receptors for two chemical messengers in the brain: dopamine, which is closely involved in psychotic symptoms and mania, and serotonin, which helps regulate mood. The body converts part of each dose into an active form, norquetiapine, which acts on serotonin receptors even more strongly and adds to the effect. Quetiapine also binds strongly to histamine receptors and blocks alpha-1 receptors, which help blood vessels tighten. These actions are not considered the source of its benefit, but the alpha-1 effect is the likely reason blood pressure can drop when someone stands up, especially in the first days of treatment.
Quetiapine comes as immediate-release tablets (Seroquel and generics), usually taken two or three times a day with or without food, and extended-release tablets (Seroquel XR and generics), taken once a day, preferably in the evening, without food or with a light meal. Extended-release tablets must be swallowed whole, not split, chewed or crushed, because they are designed to release the medicine slowly. The two forms have different dosing schedules, so a switch between them should be planned with the prescriber. Treatment starts at a low dose and is raised over a few days to a target that depends on the condition; doses for bipolar depression and add-on treatment of depression are generally lower than those for schizophrenia or mania. Older adults and people with liver disease usually start lower and increase more slowly. If doses have been missed for a week or longer, check with the prescriber before restarting, since the starting schedule may need to be repeated to avoid dizziness and fainting. Do not stop quetiapine suddenly: stopping abruptly can cause trouble sleeping, nausea and vomiting, and the prescriber can plan a gradual reduction.
Sleepiness is the most common effect, particularly in the first days of treatment and after dose increases. In bipolar depression trials, more than half of people taking quetiapine reported it, compared with about one in seven taking a placebo. Dry mouth, dizziness, constipation, weakness, indigestion and increased appetite are also common. Because quetiapine can slow thinking and coordination, avoid driving or using machinery until you know how it affects you. Lightheadedness on standing comes from a drop in blood pressure that can lead to fainting and falls; getting up slowly helps. Weight gain and metabolic changes are among the most important longer-term effects. In six-week schizophrenia trials, almost one in four adults gained 7% or more of their body weight, compared with about one in seventeen on placebo. Quetiapine can also raise blood sugar, cholesterol and triglycerides (a type of blood fat), which matters especially for people who have or are at risk of diabetes. Extreme thirst, frequent urination, unusual hunger or blurred vision can signal high blood sugar and should be reported to the care team promptly. Constipation is worth addressing rather than tolerating. Quetiapine slows the gut, and severe constipation has occasionally led to a blocked bowel, especially in people taking other medicines that slow digestion. Less common but serious effects include tardive dyskinesia, uncontrollable movements of the face, tongue, lips or limbs that can become permanent, which should be reported to the prescriber promptly. A high fever with stiff muscles, especially with confusion, heavy sweating or a fast or irregular heartbeat, can signal neuroleptic malignant syndrome, a rare but life-threatening reaction to antipsychotics that needs emergency care.
Quetiapine carries two boxed warnings, the most prominent caution the US Food and Drug Administration (FDA) requires on a label. First, older adults with dementia who are given antipsychotics for psychosis have a higher risk of death, mostly from heart problems or infections such as pneumonia, and quetiapine is not approved for that use. Second, as with antidepressants, children, teenagers and young adults under 25 may have an increased risk of suicidal thoughts and behavior, especially early in treatment or after a dose change. New or worsening depression, unusual agitation or restlessness, or thoughts of suicide should be reported to the prescriber right away, and family members can help by watching for sudden changes. Several medicines change how much quetiapine reaches the bloodstream because they affect CYP3A4, the liver enzyme that breaks it down. Some antifungals (ketoconazole, itraconazole) and the HIV medicine ritonavir raise quetiapine levels, which can deepen sedation and low blood pressure. The seizure medicines carbamazepine and phenytoin, the antibiotic rifampin and the herbal supplement St. John's wort lower levels and can make it less effective. Ask about grapefruit juice as well. Quetiapine has occasionally been linked to a prolonged QT interval, a measurement on an electrocardiogram (ECG) of how long the heart takes to reset between beats; a long QT raises the risk of a dangerous irregular rhythm. It should generally be avoided with other medicines that prolong QT, such as the heart rhythm drugs amiodarone and sotalol, the antibiotic moxifloxacin and methadone, and in people with a history of irregular heart rhythm, inherited long QT, or low potassium or magnesium. Alcohol and other sedating medicines, such as opioids and sleeping pills, add to quetiapine's drowsiness and impairment, so alcohol is best avoided or kept to a minimum. Quetiapine can strengthen the effect of blood pressure medicines and weaken levodopa and similar Parkinson's disease medicines. Studies of quetiapine in pregnancy have not shown a higher risk of birth defects or miscarriage, but babies exposed in the third trimester can have temporary agitation, stiffness, tremor, sleepiness, or breathing and feeding problems after birth. Untreated schizophrenia or bipolar disorder also carries real risks, so anyone pregnant or planning pregnancy should review the plan with the prescriber rather than stop on their own.
Sleepiness and dizziness usually appear in the first days, often before any benefit is clear, and are typically strongest while the dose is being raised. Improvement in mania, psychosis or depression is judged over weeks: the trials that established quetiapine's benefit lasted three weeks for mania and six to eight weeks for schizophrenia and bipolar depression. If it does not help enough or the side effects are hard to live with, a dose change or a different medicine may be considered. Follow-up includes regular checks of weight, blood sugar and cholesterol, and of blood pressure in children and teenagers. Eye exams for cataracts (clouding of the lens) are recommended at the start and about every six months during long-term treatment, because lens changes have been seen in people taking quetiapine for long periods. People who have had low white blood cell counts may need blood counts checked during the first months. For schizophrenia and bipolar disorder, quetiapine is often a long-term treatment. It controls symptoms rather than curing the condition, so continuing it after feeling well is usually part of the plan, while the need for it and the dose are reviewed periodically. Any decision to stop is made with the prescriber and carried out gradually.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Seroquel (Quetiapine), what you've noticed, or ask the community a question.